Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
12/28/2005 | EP1207807A4 Method for inducing hypothermia |
12/28/2005 | EP1156811B1 Copper agonist that binds on the copper binding site of amyloid precursor protein (app) and/or exerts an inhibiting effect on the release of amyloid-beta-peptide |
12/28/2005 | CN1714571A Circuit for processing video signal containing information such as closed caption |
12/28/2005 | CN1713926A Peritoneal dialysis method |
12/28/2005 | CN1713883A Oral compositions which mask the salty taste of sodium bicarbonate |
12/28/2005 | CN1712459A Antibacterial paint containing nano silver particles and coating method using the same |
12/28/2005 | CN1712348A Oxygen generating composition |
12/28/2005 | CN1712018A Externally-applied medicine for treating multiple skin diseases and production thereof |
12/28/2005 | CN1712017A Two-purpose disinfectant for skin and muscous coat, its production |
12/28/2005 | CN1233420C Method for preparation of polymeric micelle via separation of block copolymer |
12/28/2005 | CN1233329C Hypotensor composition, prepn. method and application thereof |
12/27/2005 | US6979681 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer |
12/27/2005 | US6979468 Oral composition and method for the treatment of inflammatory cutaneous disorders |
12/27/2005 | CA2346961C Patient temperature regulation method and apparatus |
12/22/2005 | WO2005120524A2 Nutritional formulations |
12/22/2005 | WO2005120523A1 Methods and compositions for treating mood disorder |
12/22/2005 | WO2005120522A1 Rheumatism preventive or therapeutic agent and beverage each comprising reduced-deuterium water |
12/22/2005 | WO2005120480A1 Antitumor effect fortifier, antitumor agent and method of therapy for cancer |
12/22/2005 | WO2005120479A1 Use of selenium or a selenium salt and a retinoid acid or a retinoid in the treatment of viral hepatitis c |
12/22/2005 | WO2005120457A1 Immune enhancing compositions and methods of use thereof |
12/22/2005 | WO2005120432A1 Dispenser for progestin used for acute and maintenance treatment of dub |
12/22/2005 | WO2005120173A2 Anti-microbial activity of biologically stabilized silver nano particles |
12/22/2005 | WO2005102366A3 Lithium combinations, and uses related thereto |
12/22/2005 | WO2005089779A3 Rapidly disintegrating taste-masked tablet |
12/22/2005 | WO2005032466A3 Calcium phosphate-based materials containig zinc, magnesium, fluoride and carbonate |
12/22/2005 | WO2004060317A3 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
12/22/2005 | US20050283045 Capsule medical instrument with oxygen generator |
12/22/2005 | US20050282904 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight |
12/22/2005 | US20050282894 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight |
12/22/2005 | US20050282794 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
12/22/2005 | US20050282783 Obtained by reacting sodium zoledronate with calcium orthophosphates in water, bone remodeling equilibrium; the local treatment of a bone problem on the main at-risk sites identified (neck of the femur ) |
12/22/2005 | US20050282752 IL-1ra variants |
12/22/2005 | US20050282751 Therapeutic agent for renal anemia |
12/22/2005 | US20050281892 Highly efficacious and highly safe composition of a Stilbene derivative and a platinum coordination compound cis-diaminedichloroplatinum (II) |
12/22/2005 | US20050281891 Testosterone stimulant |
12/22/2005 | US20050281890 Methods and compositions for wound healing |
12/22/2005 | US20050281889 Nutritional supplement for adults |
12/22/2005 | US20050281888 Nutritional supplement for infants |
12/22/2005 | US20050281887 Fluid conditioning system |
12/22/2005 | US20050281867 Nitric oxide inducing agents |
12/22/2005 | US20050281839 Spirulina composition and antiallergic food |
12/22/2005 | US20050281806 Compositions for topical enzymatic debridement |
12/22/2005 | US20050281797 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd |
12/22/2005 | US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer |
12/22/2005 | US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
12/22/2005 | US20050279252 Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
12/22/2005 | DE102004027230A1 Method for decorporating radioactive substance (e.g. radio cesium) from the body of living organisms e.g. wild pigs and deer, comprises administering food comprising ammonium-ferric(III)-hexa-cyanoferrate(II) |
12/22/2005 | CA2569738A1 Dispenser for progestin used for acute and maintenance treatment of dub |
12/22/2005 | CA2569411A1 Methods and compositions for treating mood disorder |
12/22/2005 | CA2565262A1 Nutritional formulations |
12/21/2005 | EP1607005A1 The effect of a buffering agent on acidogenesis of plaque |
12/21/2005 | EP1605967A1 Novel nph insulin preparations |
12/21/2005 | EP1605955A2 Anti-inflammatory composition based on strontium compounds |
12/21/2005 | EP1605954A1 A food-supplement composition suitable for promoting iron absorption |
12/21/2005 | EP1605950A2 Novel chemical entities and methods for their use in treatment of metabolic disorders |
12/21/2005 | EP1605912A2 Preserved ophthalmic compositions |
12/21/2005 | EP1605901A2 Selectively inhibiting estrogen production and providing estrogenic effects in the human body |
12/21/2005 | EP1282429A4 Pharmaceutical gel composition |
12/21/2005 | EP1280567B1 Nitric oxide-releasing metallic medical devices |
12/21/2005 | CN1711095A Composition for restoring damaged skin |
12/21/2005 | CN1709281A Tooth-fixing calcium phosphate |
12/21/2005 | CN1709280A Novel use of silver peroxide |
12/21/2005 | CN1709279A Smoking-stopping medicament |
12/21/2005 | CN1232263C Medication containing rare earth for treating skin disease and preparation method |
12/21/2005 | CN1232262C Eyedrop powder for treating palsy |
12/20/2005 | US6977253 Methods for the treatment of bipolar disorder using carbamazepine |
12/16/2005 | CA2505103A1 Nutritional supplement for adults |
12/16/2005 | CA2505043A1 Nutritional supplement for infants |
12/15/2005 | WO2005118776A1 Selenium-enriched biomass, method for preparing thereof and probiotic and nutraceutical products including said biomass |
12/15/2005 | WO2005117935A1 Multiple agent therapy for sexual dysfunction |
12/15/2005 | WO2005117920A1 Agent for removing factor causing circulatory dysfunction |
12/15/2005 | WO2005117919A2 Delayed-setting calcium phosphate pastes |
12/15/2005 | WO2005117918A2 Fibrous minerals, methods for their production using a solution-precursor-solid mechanism, and methods of use |
12/15/2005 | WO2005117917A2 Thermal management system and computer arrangement |
12/15/2005 | WO2005117916A1 Treatment with cisplatin and an egfr-inhibitor |
12/15/2005 | WO2005117915A1 Treatment with oxaliplatin and an egfr-inhibitor |
12/15/2005 | WO2005117914A2 Biocidal solution |
12/15/2005 | WO2005117913A2 Ozonized pharmaceutical composition and method |
12/15/2005 | WO2005117852A1 Composition for treatment of a hydrofluoric acid burn |
12/15/2005 | WO2005097084A3 Calcium salts for the treatment of psoriasis, dermatitis and dandruff |
12/15/2005 | WO2005072764A3 Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
12/15/2005 | WO2005058288A3 Antimicrobial article with diffusion control layer |
12/15/2005 | WO2005055952A3 Synergistic anti-cancer compositions |
12/15/2005 | WO2005018550B1 Enhancement of magnesium uptake in mammals |
12/15/2005 | US20050277577 Compositions and methods for treating diverticular disease |
12/15/2005 | US20050276868 Bicarbonate-based peritoneal dialysis solutions |
12/15/2005 | US20050276866 Combination comprising a CDK inhibitor and cisplatin |
12/15/2005 | US20050276865 Peroxide compounds for the prevention and treatment of sexual dysfunction in humans |
12/15/2005 | US20050276795 Chemotherapeutic and prophylactic pharmaceutical compositions |
12/15/2005 | US20050276756 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
12/15/2005 | DE102004025030A1 Nano-Apatit-Füllstoffe enthaltende härtbare Restaurationsmaterialien Nano-apatite fillers containing curable restorative materials |
12/15/2005 | CA2569508A1 Selenium-enriched biomass, method for preparing thereof and probiotic and nutraceutical products including said biomass |
12/15/2005 | CA2569234A1 Composition for treatment of a hydrofluoric acid burn |
12/15/2005 | CA2568801A1 Agent for removing circulatory dysfunction factor |
12/15/2005 | CA2568218A1 Multiple agent therapy for sexual dysfunction |
12/15/2005 | CA2567852A1 Treatment with cisplatin and an egfr-inhibitor |
12/15/2005 | CA2566974A1 Treatment with oxaliplatin and an egfr-inhibitor |
12/15/2005 | CA2566571A1 Treatment methods utilizing albumin-binding proteins as targets |
12/15/2005 | CA2566518A1 Compositions and methods using same for treating neurodegenerative disorders |
12/15/2005 | CA2563697A1 Ozonized pharmaceutical composition and method |